BRIEF published on 04/02/2026 at 19:05, 1 month 14 days ago Medincell: Update on capital and voting rights Share Capital Voting Rights Shares Euronext AMF
PRESS RELEASE published on 04/02/2026 at 19:00, 1 month 14 days ago Informations privilégiées / Autres communiqués Euronext MEDCL divulgue les chiffres du capital social et des droits de vote conformément au règlement de l'AMF. Medincell développe des traitements biopharmaceutiques innovants à action prolongée Droits De Vote Euronext Capital Social Medincell MEDCL
BRIEF published on 02/20/2026 at 21:42, 2 months 24 days ago Teva's Olanzapine Injectable Suspension Gains FDA Nod Schizophrenia Olanzapine Teva Pharmaceuticals FDA Acceptance Long-acting Injectable
BRIEF published on 02/20/2026 at 21:42, 2 months 24 days ago La suspension injectable d'olanzapine de Teva obtient l'approbation de la FDA Schizophrénie Olanzapine Teva Pharmaceuticals Acceptation Par La FDA Injectable À Action Prolongée
PRESS RELEASE published on 02/20/2026 at 21:37, 2 months 24 days ago Informations privilégiées / Autres communiqués La FDA américaine accepte le dossier de demande de mise sur le marché de l'Olanzapine LAI par Teva pour le traitement de la schizophrénie chez l'adulte. Une nouvelle option thérapeutique innovante pourrait bientôt être disponible FDA Schizophrénie Traitement Teva Olanzapine LAI
PRESS RELEASE published on 02/20/2026 at 21:37, 2 months 24 days ago Inside Information / Other news releases FDA accepts Teva's NDA for once-monthly olanzapine for schizophrenia treatment, addressing treatment gap. Teva and Medincell collaborate for innovative solution FDA Schizophrenia Medincell Olanzapine Teva
BRIEF published on 02/19/2026 at 10:33, 2 months 26 days ago Franchissement de seuil par Mirova chez MEDINCELL Euronext Paris Droits De Vote Cession D'actions Medincell Mirova
BRIEF published on 02/19/2026 at 10:33, 2 months 26 days ago Mirova crosses a threshold at MEDINCELL Euronext Paris Voting Rights Transfer Of Shares Mirova MEDICELL
PRESS RELEASE published on 02/19/2026 at 10:28, 2 months 26 days ago Franchissement de seuil Déclaration de franchissement de seuil de la société MedinCell par Mirova. Baisse à 6,44% du capital et 4,89% des droits de vote Franchissement De Seuil AMF Baisse Medincell Mirova
BRIEF published on 12/09/2025 at 14:55, 5 months 8 days ago Medincell et Teva soumettent une demande d'autorisation de mise sur le marché auprès de la FDA pour un nouveau traitement injectable. Traitement De La Schizophrénie Medincell Soumission À La FDA Teva Pharmaceuticals Olanzapine LAI
Published on 05/16/2026 at 01:15, 1 day 14 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 15 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 16 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 23 hours 29 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 19 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 21 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 5 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 6 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 21 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
